EA200802421A1 - METHOD OF TREATMENT ENDOMETRIOSIS - Google Patents

METHOD OF TREATMENT ENDOMETRIOSIS

Info

Publication number
EA200802421A1
EA200802421A1 EA200802421A EA200802421A EA200802421A1 EA 200802421 A1 EA200802421 A1 EA 200802421A1 EA 200802421 A EA200802421 A EA 200802421A EA 200802421 A EA200802421 A EA 200802421A EA 200802421 A1 EA200802421 A1 EA 200802421A1
Authority
EA
Eurasian Patent Office
Prior art keywords
treatment
drug
endometriosis
course
treatment endometriosis
Prior art date
Application number
EA200802421A
Other languages
Russian (ru)
Other versions
EA016009B1 (en
Inventor
Ольга Анатольевна Хоперская
Original Assignee
Закрытое акционерное общество "СКАЙ ЛТД"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Закрытое акционерное общество "СКАЙ ЛТД" filed Critical Закрытое акционерное общество "СКАЙ ЛТД"
Publication of EA200802421A1 publication Critical patent/EA200802421A1/en
Publication of EA016009B1 publication Critical patent/EA016009B1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Изобретение относится к медицине, в частности, к лечению эндометриоза. Согласно способа лечения эндометриоза в течении курса лечения пациентке вводят лекарственный препарат, причем в качестве препарата используют гликопротеин, выделенный из фолликулярной жидкости крупного рогатого скота, причем в процессе курса лечения данный препарат вводят в дозе 150-600 мг, а курс лечения составляет 10-30 инъекций препарата в зависимости от степени выраженности эндометриоза.The invention relates to medicine, in particular, to the treatment of endometriosis. According to the method of treating endometriosis during the course of treatment, the patient is injected with a drug, and a glycoprotein isolated from the follicular liquid of cattle is used as a drug, and during the course of treatment this drug is administered in a dose of 150-600 mg, and the course of treatment is 10-30 injections of the drug, depending on the severity of endometriosis.

EA200802421A 2008-01-23 2008-12-17 Method for treating endometriosis EA016009B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2008101585/14A RU2359684C1 (en) 2008-01-23 2008-01-23 Way of endometriosis treatment

Publications (2)

Publication Number Publication Date
EA200802421A1 true EA200802421A1 (en) 2009-08-28
EA016009B1 EA016009B1 (en) 2012-01-30

Family

ID=41027084

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200802421A EA016009B1 (en) 2008-01-23 2008-12-17 Method for treating endometriosis

Country Status (2)

Country Link
EA (1) EA016009B1 (en)
RU (1) RU2359684C1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2732251C1 (en) * 2019-11-29 2020-09-14 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт акушерства, гинекологии и репродуктологии имени Д.О. Отта" Method of treating external genital endometriosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681817A (en) * 1994-02-04 1997-10-28 The Medical College Of Hampton Roads Treatment of ovarian estrogen dependent conditions
RU2201241C2 (en) * 2001-06-06 2003-03-27 Закрытое акционерное общество "СКАЙ ЛТД" Method of purification of protein of family of growth transforming factors prepared from follicular fluid
FR2827290B1 (en) * 2001-07-13 2004-07-09 Pierre Jouan Biotechnologies Sa METHOD FOR OBTAINING A PROTEIN FRACTION ENRICHED IN ACTIVATED FORM TGF-BETA, PROTEIN FRACTION AND THERAPEUTIC APPLICATIONS

Also Published As

Publication number Publication date
EA016009B1 (en) 2012-01-30
RU2359684C1 (en) 2009-06-27

Similar Documents

Publication Publication Date Title
WO2008039898A3 (en) Methods for the treatment of a traumatic central nervous system injury
CY1113253T1 (en) Dosage regimen for therapeutic treatment of a traumatic brain injury with progesterone
MX2013004406A (en) Treating diabetes melitus using insulin injections administered with varying injection intervals.
EA201590902A1 (en) METHODS AND DEVICES APPLICABLE FOR THE TREATMENT OF EYE DISEASES IN HUMAN
BRPI0518460A2 (en) Method for treating an allergic emergency in a patient, drug delivery device containing an epinephrine solution, and kit for treating an allergic emergency '
NZ599558A (en) Dosing regimen associated with long-acting injectable paliperidone esters
RU2008138381A (en) ADRENALINE DOSAGE MODES
MX2019007779A (en) Method of treating or reducing efp.
MX2018013715A (en) Aqueous based capsaicinoid formulations, and treatment in combination with a corticosteroid.
NZ744233A (en) Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack
BR112015004110A2 (en) prostate drug delivery systems and methods
BR112015003836A2 (en) drug delivery systems and methods for bladder cancer treatment
MX2016006179A (en) Aqueous based capsaicinoid formulations and methods of manufacture and use.
Behdad et al. Effect of gabapentin on postoperative pain and operation complications: a randomized placebo controlled trial.
AR088204A1 (en) MEDICINES FOR THE TREATMENT OF ALLERGY RHINITIS THAT INCLUDE A PGD2 ANTAGONIST AND A HISTAMINE ANTAGONIST
JP2014530246A5 (en)
WO2007100590A3 (en) Methods for treating cellulite
EA200802421A1 (en) METHOD OF TREATMENT ENDOMETRIOSIS
BR112013010345A2 (en) diabetes mellitus treatment using insulin injections administered at varying injection intervals
Loo Is ketamine ready to be used clinically for the treatment of depression
EA200801388A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF TUBERCULOSIS AND DISEASES MEDIATED BY HELICOBACTER PILORY BASED ON POLYMERIC NANOPARTICLES, ITS TREATMENT METHOD AND TREATMENT METHOD
Kavandi Interferon-α-2a
RU2007120403A (en) METHOD FOR LOCAL THERAPY OF AUTOIMMUNE ARTHRITIS
Mota Esomeprazole/pantoprazole
Brodell Subcutaneous lipoatrophy treated with polylactic acid: case report

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AZ KG MD TJ TM